Cronos Group Inc.
No SEC Form 4 filings for $CRON in the last 30 days.
See all $CRON insider activity →Cronos Group Inc. (CRON) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 pressreleaseq22026qformat.htm EX-99.1 Document Cronos Group Reports 2026 Second Quarter Results Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q2 2026 increased by 51% year-over-year on an organic, co
Cronos Group Inc. (CRON) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. cron-20260618 false CRONOS GROUP INC. 0001656472 Stayner Canada 001-38403 Ontario 0001656472 2026-06-18 2026-06-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 193
A federal grand jury in California convicted short seller Andrew Left of securities fraud, the U.S. Justice Department said. He was found guilty of one count of participating in a securities fraud scheme and 12 securities fraud counts. Prosecutors said he profited over $20 million from 2018-2023 via trades tied to Citron Research commentary on companies including Tesla and Nvidia. Sentencing is Aug. 31; he faces up to 25 years.
Over the past 7 days, alphai's AI scored 1 news story mentioning CRON (Cronos Group Inc.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent CRON coverage spans financial news, regulation and earnings.
The 8-K discloses a sharp profitability rebound and ongoing buybacks, which can re-rate near-term sentiment and support downside risk control.
The filing confirms governance outcomes (board slate, say-on-pay, auditor) but provides no new financial guidance or deal terms.
CRON’s inclusion is indirect; the conviction may prompt broader retail-investor/regulatory attention but not company-specific change.
Conviction may heighten scrutiny of influencer/short-seller tactics in CRON-related trading narratives.
No new Q1 datapoints are provided; the piece is primarily promotional/forward-looking around CRON’s upcoming/just-reported Q1 reaction.
alphai scores every news story that mentions CRON with an AI model for sentiment and relevance, and aggregates insider trades from Cronos Group Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Cronos Group Inc. (CRON) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 pressreleaseq22026qformat.htm EX-99.1 Document Cronos Group Reports 2026 Second Quarter Results Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q2 2026 increased by 51% year-over-year on an organic, co
7 min readCronos Group Inc. (CRON) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. cron-20260618 false CRONOS GROUP INC. 0001656472 Stayner Canada 001-38403 Ontario 0001656472 2026-06-18 2026-06-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 193
2 min readA federal grand jury in California convicted short seller Andrew Left of securities fraud, the U.S. Justice Department said. He was found guilty of one count of participating in a securities fraud scheme and 12 securities fraud counts. Prosecutors said he profited over $20 million from 2018-2023 via trades tied to Citron Research commentary on companies including Tesla and Nvidia. Sentencing is Aug. 31; he faces up to 25 years.
5 min readActivist short seller Andrew Left, founder of Citron Research, was convicted in Los Angeles federal court of securities fraud for allegedly manipulating stock prices using his social-media following. A jury found him guilty on 1 scheme count and 12 securities-fraud counts; prosecutors said he profited about $20 million. He plans to appeal and faces sentencing Aug. 31, with up to 25 years on the lead count.
4 min readThe article discusses generative AI and robotics potential, citing statements by Amazon CEO Andy Jassy, Elon Musk’s prediction of 10 billion humanoid robots by 2040, and comments from Bill Gates, Larry Ellison and Warren Buffett. It also claims Cronos Group (CRON) shares were rising ahead of Q1 results, but provides no Q1 figures. It promotes a paid newsletter, asserting management cut $100 million in waste and citing “400% upside” for an unspecified “$3” stock.
7 min readCronos Group executive Arye Weigensberg exercised 3,118 restricted stock units (RSUs) into common shares, increasing his direct holdings to 211,555 shares. This compensation-related transaction, reported on May 10, 2026, did not involve any share sales, and Weigensberg retains 154,419 RSUs. The filing is categorized as neutral in its market impact and sentiment.
2 min readCronos Group (TSE:CRON) has announced a new $50 million share repurchase program following a strong first quarter in 2026, which saw a 40% year-over-year revenue increase to $45.2 million and record gross profit. The company also extended the deadline for its CanAdelaar B.V. acquisition to September 2026 to secure necessary Dutch regulatory approvals. Spark, TipRanks’ AI Analyst, rates CRON as Neutral, noting strong financial resilience but weak bottom-line profitability.
3 min readThis article provides an investment analysis for Cronos Group Inc. (CRON:CA), including AI-generated trading signals for near, mid, and long terms, and recommended trading plans. It suggests buying near 3.24, targeting 3.73, and using a stop loss at 3.22, or shorting near 3.73, targeting 3.24, with a stop loss at 3.75. The analysis is current as of January 5, 2026.
4 min readCronos Group's stock price has risen by 11.93% due to significant investor optimism following its strategic expansion into Europe. The company plans to acquire CanAdelaar, Europe's largest adult-use cannabis sector player, for $67 million, and has also unveiled new Lord Jones Live Resin Fusions pre-rolls in Canada. This move aims to boost Cronos's European footprint and capitalize on evolving cannabis markets.
3 min readCronos Group Inc. is acquiring CanAdelaar, Europe's largest adult-use cannabis company, for an upfront cash payment of US$67 million. CanAdelaar manages the only industrial-scale greenhouse among the Netherlands' "Wietexperiment" pilot program providers, capable of producing 20,000 kilograms of dried flower annually. This acquisition gives Cronos access to an emerging European market with significant growth potential, although regulatory risks associated with the pilot program's temporary nature remain.
3 min read
